{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:15:13Z","timestamp":1788138913485,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Municipal Natural Science Foundation","award":["7222264"],"award-info":[{"award-number":["7222264"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271825"],"award-info":[{"award-number":["82271825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02208-1","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:43:07Z","timestamp":1781692987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Absence of osteoclastogenic response to pooled polyclonal anti-citrullinated peptide\/protein antibodies from patients with rheumatoid arthritis in vitro"],"prefix":"10.1007","volume":"26","author":[{"given":"Xiaoli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"7","key":"2208_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18(7):415\u201329. https:\/\/doi.org\/10.1038\/s41584-022-00793-5.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"2208_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580\u20138. https:\/\/doi.org\/10.1136\/ard.2010.138461.","journal-title":"Ann Rheum Dis"},{"key":"2208_CR3","doi-asserted-by":"publisher","first-page":"802934","DOI":"10.3389\/fmed.2021.802934","volume":"8","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Wu Z, et al. Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects. Front Med (Lausanne). 2022;8:802934. https:\/\/doi.org\/10.3389\/fmed.2021.802934.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"2208_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.semarthrit.2017.10.009","volume":"47","author":"E Alemao","year":"2018","unstructured":"Alemao E, Guo Z, Frits ML, et al. Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study. Semin Arthritis Rheum. 2018;47(5):630\u20138. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.10.009.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"2208_CR5","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","volume":"73","author":"A Kleyer","year":"2014","unstructured":"Kleyer A, Finzel S, Rech J, et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis. 2014;73(5):854\u201360. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202958.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2208_CR6","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/biomedicines12102376","volume":"12","author":"M Moret","year":"2024","unstructured":"Moret M, Morizot C, de Carvalho Bittencourt M, et al. A Clinical Evaluation of the Role of Autoimmunity in the Relation Between Erosions and Bone Mineral Density in Rheumatoid Arthritis. Biomedicines. 2024;12(10):2376. https:\/\/doi.org\/10.3390\/biomedicines12102376.","journal-title":"Biomedicines"},{"issue":"5","key":"2208_CR7","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012;122(5):1791\u2013802. https:\/\/doi.org\/10.1172\/JCI60975.","journal-title":"J Clin Invest"},{"issue":"4","key":"2208_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","volume":"75","author":"A Krishnamurthy","year":"2016","unstructured":"Krishnamurthy A, Joshua V, Haj Hensvold A, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis. 2016;75(4):721\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208093.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2208_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/annrheumdis-2015-208093corr1","volume":"78","author":"Correction","year":"2019","unstructured":"Correction. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis. 2019;78(6):866. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208093corr1.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2208_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.2012148612112018r","volume":"216","author":"K Amara","year":"2019","unstructured":"Amara K, Steen J, Murray F, et al. Retraction: Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med. 2019;216(1):245. https:\/\/doi.org\/10.1084\/jem.2012148612112018r.","journal-title":"J Exp Med"},{"key":"2208_CR11","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1038\/ncomms7651","volume":"6","author":"U Harre","year":"2015","unstructured":"Harre U, Lang SC, Pfeifle R. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun. 2015;6:6651. https:\/\/doi.org\/10.1038\/ncomms7651.","journal-title":"Nat Commun"},{"issue":"1","key":"2208_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","volume":"14","author":"Y He","year":"2023","unstructured":"He Y, Ge C, Moreno-gir\u00f3 \u00c0, et al. A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. Nat Commun. 2023;14(1):691. https:\/\/doi.org\/10.1038\/s41467-023-36257-x.","journal-title":"Nat Commun"},{"issue":"2","key":"2208_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/art.42679","volume":"76","author":"AM Gomez","year":"2024","unstructured":"Gomez AM, Brewer RC, Moon JS, et al. Anti-Citrullinated Protein Antibodies with Multiple Specificities Ameliorate Collagen Antibody-Induced Arthritis in a Time-Dependent Manner. Arthritis Rheumatol. 2024;76(2):181\u201391. https:\/\/doi.org\/10.1002\/art.42679.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"2208_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/ard-2022-223417","volume":"82","author":"B Raposo","year":"2023","unstructured":"Raposo B, Afonso M, Israelsson L, et al. Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Ann Rheum Dis. 2023;82(5):724\u20136. https:\/\/doi.org\/10.1136\/ard-2022-223417.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2208_CR15","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/ar4683","volume":"16","author":"E Ossipova","year":"2014","unstructured":"Ossipova E, Cerqueira CF, Reed E, et al. Affinity purified anti-citrullinated protein\/peptide antibodies target antigens expressed in the rheumatoid joint. Arthritis Res Ther. 2014;16(4):R167. https:\/\/doi.org\/10.1186\/ar4683.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2208_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/ijms19010326","volume":"19","author":"E Szarka","year":"2018","unstructured":"Szarka E, Aradi P, Huber K, et al. Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis. Int J Mol Sci. 2018;19(1):326. https:\/\/doi.org\/10.3390\/ijms19010326.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2208_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/art.40699","volume":"71","author":"J Steen","year":"2019","unstructured":"Steen J, Forsstr\u00f6m B, Sahlstr\u00f6m P, et al. Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis. Arthritis Rheumatol. 2019;71(2):196\u2013209. https:\/\/doi.org\/10.1002\/art.40699.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"2208_CR18","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1093\/rheumatology\/kead130","volume":"62","author":"M Kawataka","year":"2023","unstructured":"Kawataka M, Ouhara K, Kobayashi E, et al. N-glycan in the variable region of monoclonal ACPA (CCP-Ab1) promotes the exacerbation of experimental arthritis. Rheumatology (Oxford). 2023;62(12):3968\u201377. https:\/\/doi.org\/10.1093\/rheumatology\/kead130.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2208_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41584-022-00867-4","volume":"19","author":"T Kissel","year":"2023","unstructured":"Kissel T, Toes REM, Huizinga TWJ, Wuhrer M. Glycobiology of rheumatic diseases. Nat Rev Rheumatol. 2023;19(1):28\u201343. https:\/\/doi.org\/10.1038\/s41584-022-00867-4.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"2208_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/art.41666","volume":"73","author":"K Yokota","year":"2021","unstructured":"Yokota K, Sato K, Miyazaki T, Aizaki Y, Tanaka S, Sekikawa M, Kozu N, Kadono Y, Oda H, Mimura T. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis. Arthritis Rheumatol. 2021;73(7):1145\u201354. https:\/\/doi.org\/10.1002\/art.41666.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2208_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/25785826.2023.2220931","volume":"47","author":"K Yokota","year":"2024","unstructured":"Yokota K. Osteoclast differentiation in rheumatoid arthritis. Immunol Med. 2024;47(1):6\u201311. https:\/\/doi.org\/10.1080\/25785826.2023.2220931.","journal-title":"Immunol Med"},{"issue":"11","key":"2208_CR22","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3390\/ijms21114015","volume":"21","author":"CY Wu","year":"2020","unstructured":"Wu CY, Yang HY, Lai JH. Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis. Int J Mol Sci. 2020;21(11):4015. https:\/\/doi.org\/10.3390\/ijms21114015.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2208_CR23","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar3237","volume":"13","author":"H Kokkonen","year":"2011","unstructured":"Kokkonen H, Mullazehi M, Berglin E, et al. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther. 2011;13(1):R13. https:\/\/doi.org\/10.1186\/ar3237.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2208_CR24","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/rheumatology\/keaa761","volume":"60","author":"A Di Matteo","year":"2012","unstructured":"Di Matteo A, Mankia K, Nam JL, et al. In anti-CCP\u2009+\u2009at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Rheumatology (Oxford). 2012;60(7):3156\u201364. https:\/\/doi.org\/10.1093\/rheumatology\/keaa761.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02208-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02208-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:45:35Z","timestamp":1788137135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02208-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02208-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking University Third Hospital (No. M20250032).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"310"}}